Short answer
Tevogen Bio Holdings Inc. (TVGN) filed an 8-K current report with the SEC on August 26, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Annual stockholder meeting held August 24, 2026.
Tevogen Bio Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Annual stockholder meeting held August 24, 2026
- Section identifies officer-related matters, but provided text is incomplete
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Certificate of Amendment filed August 26, 2026, following Board recommendation and stockholder approval
- Stockholders may now act by written consent instead of holding a meeting
- Immediate effectiveness upon Delaware Secretary of State filing
- Governance change could accelerate shareholder-approved corporate actions
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 5,956,141 shares represented, establishing quorum against 6,416,540 outstanding shares
- Directors Keow Lin Goh and Victor Sordillo elected to three-year Class II terms
- KPMG LLP appointment ratified for fiscal 2026, with 5,939,035 votes supporting
- 2024 Plan amendment approved with 5,322,668 votes, potentially expanding equity-compensation flexibility
- Charter amendment approved, allowing stockholders to act by written consent without a meeting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tevogen Bio Holdings Inc. 8-K filings
Get the next TVGN 8-K as it lands
Follow TVGN for push alerts, or ask the research agent what this filing means.